Preserve Access to Affordable Generics and Biosimilars Act

119-s1096 — Preserve Access to Affordable Generics and Biosimilars Act. Sponsored by Sen. Klobuchar, Amy [D-MN]. Introduced 2025-03-24. Senate bill. 119th Congress. Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 46.

119-s1096 119th Congress Senate
XML

Bill Activity

House
Introduced
2005-05-23
Read twice and referred to the Committee on Energy and Natural Resources. (text of measure as introduced: CR S5780-5781)
Committee
2005-09-22
Committee on Energy and Natural Resources Subcommittee on National Parks. Hearings held. With printed Hearing: S.Hrg. 109-213.
Committee
2005-11-16
Committee on Energy and Natural Resources. Ordered to be reported without amendment favorably.
Committee
2005-12-08
Committee on Energy and Natural Resources. Reported by Senator Domenici under authority of the order of the Senate of 11/18/2005 without amendment. With written report No. 109-193.
Committee
2005-12-17
Referred to the House Committee on Resources.
Committee
2005-12-21
Referred to the Subcommittee on National Parks.
Committee
2006-12-09
Committee on Resources discharged.
House Floor Vote
2006-12-09
Passed/agreed to in House: On passage Passed without objection.(text: CR 12/8/2006 H9254-9255)
Senate
Introduced in Senate
2025-03-24
Senate Floor Vote
2005-12-16
Passed Senate with an amendment by Unanimous Consent.
President
President
2006-12-20
Presented to President.
Became Law
2006-12-22
Became Public Law No: 109-452.
Sponsor
Sen. Klobuchar, Amy [D-MN] (D), MN
Introduced
2025-03-24
Committees
Judiciary Committee
Subjects
Administrative law and regulatory procedures; Civil actions and liability; Competition and antitrust; Contracts and agency; Federal Trade Commission (FTC); Intellectual property; Judicial review and appeals; Licensing and registrations; Manufacturing; Marketing and advertising; Prescription drugs
Latest Action
Placed on Senate Legislative Calendar under General Orders. Calendar No. 46.

No roll-call vote data available for this bill.

Explore This Bill

Investigate this bill → AI summary, roll-call breakdown, and full bill analysis